Pradaxa Drug Marketing

533 Words2 Pages

Question 5

The adoption of pradaxa is difficult as it interacts with various types of foods and regular monitoring of the drug for proper administration. Praxada is a newly introduced drug therefore, doctors continue to gain experience on its administration thus patients are opting to use other competing drugs like Warfarin. Market entry barrier poses a threat to the adoption of the pradaxa drug. Pradaxa being a newly introduced drug implies a high investment cost associated with its introduction to the market. The Federal government strictly regulates marketing registration of the drug and the authorization of the sale of these drugs. Many marketing risks associated with the drug poses some barriers as they inhibit or stimulate the adoption of the new researched drug. The pradaxa drug also faces the problem of patent protection duration since the administrative procedures take more time and this creates the barrier to quick adoption of the drug. Pradaxa drug is costly and this limits its adoption and improved sales in the local market since few people can afford to use it. The dosage accompanies specific food for it to be effective and through taking high dosage the patients seem to improve at a higher rate as compared to those who take small dosage (Leidner & galliers, 2003).

Question 6

From the above issues the development and marketing of pradaxa drug requires a strategic planning since it can take centuries to launch a newly developed drug in the market. The effectiveness of a drug reveals itself when tested on the patients and cures the described illness. Pradaxa is a drug used in the prevention of strokes and blood clot, and to ensure that the drug is effective on the patients a trial is made on more than ten patients with different levels of stroke and blood clot to find out the situation which guarantees its use. The drug faces stiff competition from other drugs like Warfarin in the drug market and this call for a solution to ensure that it makes the greatest sales. There are also competing companies like J&J and Bayer and Pfizer but their drugs fail to outdo pradaxa since they fail to overcome its strength. Presence of competition shows that the business is improving and the best way to ensure that the product is competing adequately in the market is through laying good marketing strategies. According to Hashad (2010) the marketing strategy is targeted to take three years with the first face being focused on the healthcare providers, the nurses, doctors and patients.

Open Document